AT&S Employs Innovative PCB Technology to Hearing Aids and Pacemakers to Prostheses


Reading time ( words)

The trend for miniaturization and digitalization is shaping medical technology, too. Systems and components for treatment, diagnosis and patient monitoring are becoming ever smaller and more powerful. In medical technology, more than any other field, safety and reliability – despite progressive miniaturization – are an absolute priority, since reliable functioning can be vitally important.

With its innovative and sophisticated interconnection technologies, AT&S is enabling a wide variety of applications – some of them entirely new – both on and inside the human body. The company is one of the few printed circuit board (PCB) manufacturers that is certified to EN ISO 13485, the standard for medical devices. Thanks to the performance and quality of its products, paired with extensive technical and consulting expertise in the medical sector, AT&S is contributing to making even smaller and more powerful products for medical treatment, monitoring vital functions (blood sugar, blood pressure, ECG) and diagnosis/imaging (MRT, X-ray, ultrasound). Extremely compact pacemakers with long battery life, hearing aids with intelligent adjustment, local neurostimulators for pain therapy, and cochlear implants allow improved and new treatment methods to benefit patients.

The key challenges in medical technology are advancing miniaturization, maximum quality, and developing new biocompatible materials. With its sophisticated, reliable technologies, AT&S has for many years been a world-leading PCB supplier for hearing aids, for example. State-of-the-art cochlear implants also use AT&S technology. A cochlear implant is an electronic medical device that performs the function of damaged parts of the inner ear (cochlea) to transmit sounds to the brain.

Miniaturized PCBs are also facilitating completely new treatment approaches. For example, the functionality of a human hand – representing a highly complex system – has been largely replicated in a prosthesis using the latest interconnection technology from AT&S. “Smart capsules” are now a reality too. Using highly miniaturized PCB technology as a substrate for the electronics, they are able to monitor specific body parameters and transmit the relevant data or deliver a controlled dose of medication. Finally, extremely compact interconnection technologies are also being used in wearables and tracking systems for lifestyle applications.

“Medical technology is facing great challenges with regard to demographic changes and the modern lifestyle,” says Walter Moser, Chief Sales Officer (CSO) of the Business Unit Automotive, Industrial and Medical at AT&S. “With our advanced, constantly developing interconnection technologies and our consulting expertise, we are ideally positioned to help our customers find solutions to these current problems. That includes new cost-efficient, patient-friendly treatments and diagnostic procedures, as well as user-optimized monitoring solutions.”

AT&S will present its innovative PCB technologies for medical technology at COMPAMED (13-16 November 2017) in Düsseldorf (hall 8b, stand F04).

Share


Suggested Items

Patty's Perspective: (Signal) Integrity for All

10/09/2017 | Patty Goldman, I-Connect007
Our topic this month is signal integrity, certainly a common one in our industry. Signal integrity is achieved by controlling impedance, so my advice is to do that. There, I’m done. Just kidding…of course I’m not done. But if you are in PCB manufacturing and you think this is just a design problem and doesn’t concern you, please think again.

Catching up with FineLine Global

10/03/2017 | Dan Beaulieu, D.B. Management Group
With locations all over the world and technology offerings covering all technologies, I wanted to see for myself what this “broker on steroids” was all about—how they got started and how they grew. So I was delighted to have a conversation with Eli Ikan, Fineline Global’s General Manager.

Institute of Circuit Technology Hayling Island Seminar 2017

10/04/2017 | Pete Starkey, I-Connect007
This year’s event had a well-chosen and varied programme featuring presentations on process chemistry and R&D consortia, a discussion of controversial standards proposals and a review of the experiences of commissioning new technology in a start-up factory.



Copyright © 2017 I-Connect007. All rights reserved.